Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant <i>Staphylococcus aureus</i> Endocarditis

1991580 citationsJournal Article

Authors

Donald P. Levine · Wayne State University

Barbara S. Fromm · Harper University Hospital

B. Ramesh Reddy · Harper University Hospital

Abstract

Slow clinical response is common among patients with MRSA endocarditis who are treated with vancomycin or vancomycin plus rifampin. Nevertheless, few complications appear to be related solely to this sustained bacteremia.

Topics & Keywords

Antimicrobial Resistance in Staphylococcus Infective Endocarditis Diagnosis and Management Bacterial Identification and Susceptibility Testing

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Internal Medicine

Volume 115, Issue 9, pp. 674-680

DOI: 10.7326/0003-4819-115-9-674

Field-Weighted Citation Impact: 9.88